Long-limb or Distal Gastric Bypass for Superobesity - Randomized Study

September 3, 2021 updated by: Tom Mala, Oslo University Hospital

Long -Limb Gastric or Distal Gastric Bypass in the Treatment of Super Obese Patients - a Prospective Randomized Study

The main study objective:

To evaluate long-limb gastric bypass (150 cm alimentary limb) vs. "distal" gastric bypass (common channel 150 cm) in the treatment of superobesity (BMI 50-60 kg/m2).

The main study hypothesis:

Distal bypass accomplish an estimated 10-20 % larger weightloss than long-limb gastric bypass 1 year after surgery. Patients subject to distal bypass have more gastrointestinal side effects and more extensive nutritional deficiences compared to long-limb gastric bypass.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Technical data will later be published in detail

Study Type

Interventional

Enrollment (Actual)

115

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0514
        • Aker university Hospital, Surgical Dep., The Hospital of Vestfold, Surgical Dep.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 58 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI 50 - 60 kg/m2 at admission for evaluation for bariatric surgery
  • BMI 48 - 62 kg/m2 at study inclusion
  • informed consent
  • scheduled for bariatric surgery

Exclusion Criteria:

  • previous bariatric surgery
  • previous major abdominal surgery
  • previous history or established urolithiasis
  • viral hepatitis, liver cirrhosis of any kind
  • factors making the patient not eligible to understand and commit to the study protocol (severe psychiatric disease or drug/narcotic abuse)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: long-limb bypass
Laparoscopic long-limb gastric bypass (150 cm alimentary limb, 50 cm biliopancreatic limb)
Laparoscopic long-limb gastric bypass (150 cm alimentary limb, 50 cm biliopancreatic limb)
Active Comparator: Distal gastric bypass
Laparoscopic distal gastric bypass (150 cm common channel, 50 cm biliopancreatic limb)
Laparoscopic distal gastric bypass (150 cm common channel, 50 cm biliopancreatic limb)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary outcome: weight loss
Time Frame: 2 years postoperatively
physical examination
2 years postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary outcome: Quality of life
Time Frame: 2 years postoperative
questionnaire
2 years postoperative
Adverse events
Time Frame: 2 years postoperative
medical history, journals
2 years postoperative
Number of patients with vitamin deficiencies
Time Frame: 2 years postoperative
Blood samples
2 years postoperative
Number of patients with mineral deficiencies
Time Frame: 2 years postoperative
Blood samples
2 years postoperative
Number of participants with malnutrition
Time Frame: 2 years postoperative
Blood samples
2 years postoperative
Weight loss 5 year
Time Frame: 5 year postoperative
physical examination
5 year postoperative
Health related Quality of life
Time Frame: 5 years postoperative
questionnaire
5 years postoperative
Number of patients with malnutrition
Time Frame: 5 years postoperative
Blood samples
5 years postoperative
Number of patients with mineral deficiencies
Time Frame: 5 years postoperative
Blood samples
5 years postoperative
Number of patients with vitamin deficiencies
Time Frame: 5 years postoperative
Blood samples
5 years postoperative
Adverse events
Time Frame: 5 years
Medical history, journals
5 years
Weight loss 10 years
Time Frame: 10 years postoperative
Weight measure
10 years postoperative
Adverse events
Time Frame: 10 years postoperative
Medical history, journals
10 years postoperative
Number of patients with malnutrition
Time Frame: 10 years postoperative
Blood samples
10 years postoperative
Number of patients with mineral deficiencies
Time Frame: 10 years postoperative
Blood samples
10 years postoperative
Number of patients with vitamin deficiencies
Time Frame: 10 years postoperative
Blood samples
10 years postoperative
Health related Quality of life
Time Frame: 10 years postoperative
questionnaire
10 years postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Tom Mala MD, PhD Rune Sandbu, MD, PhD, Aker University Hospital / The Hospital of Vestfold

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2011

Primary Completion (Actual)

May 1, 2015

Study Completion (Anticipated)

May 1, 2025

Study Registration Dates

First Submitted

January 12, 2009

First Submitted That Met QC Criteria

January 12, 2009

First Posted (Estimate)

January 13, 2009

Study Record Updates

Last Update Posted (Actual)

September 5, 2021

Last Update Submitted That Met QC Criteria

September 3, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • AT-0910-ST

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on long-limb gastric bypass

3
Subscribe